Perigon Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,114
Closed -$293K 879
2024
Q1
$293K Buy
2,114
+54
+3% +$6.79K 0.01% 690
2023
Q4
$256K Buy
+2,060
New +$210K 0.01% 712
2023
Q3
Sell
-1,853
Closed -$238K 791
2023
Q2
$238K Buy
+1,853
New +$224K 0.01% 686
2023
Q1
Sell
-3,192
Closed -$361K 707
2022
Q4
$361K Buy
+3,192
New +$350K 0.02% 474
2021
Q1
Sell
-232
Closed -$21K 637
2020
Q4
$21K Buy
+232
New +$20.7K ﹤0.01% 1022

Other funds holding DXCM

Perigon Wealth Management's DXCM Position: Q2 2024 in Review

Perigon Wealth Management sold out of DexCom (DXCM) in Q2 2024, closing a stake of 2,114 shares — an estimated $293K sold.

Perigon Wealth Management first reported a position in DXCM in Q4 2020 and held it in 5 quarters. The position peaked at $361K in Q4 2022. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Perigon Wealth Management reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Perigon Wealth Management sold 2,114 DexCom shares in Q2 2024, an estimated $293K.
  • Perigon Wealth Management first reported a position in DexCom in Q4 2020 and held it in 5 quarters.
  • Perigon Wealth Management's DexCom position peaked at $361K in Q4 2022.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Perigon Wealth Management's 13F filing for Q2 2024, filed 2 Aug 2024.